H|T: The Healthtech Times – Telus to buy LifeWorks for $2.3B
Plus: Residents say China used health tracker for crowd control.
Healthtech
DOT Mind Unlock wins #CollisionConf 2022 startup pitch competition
DOT can measure people’s brainwave activity using headsets.
H|T: The Healthtech Times – Changing how doctors get paid
Plus: Teladoc Health faces class action lawsuit alleging it misled investors.
H|T: The Healthtech Times – The 🇨🇦 company taking the pain out of patient transfer
Plus: Quebec’s medical records database still only accessible via Internet Explorer.
IntelliSports raises $2.5 million for gamified fitness app PlayFitt
New York Jets’ guard bets on Montréal-made fitness video game.
H|T: The Healthtech Times – Inside Canada’s Indeed for doctors
Plus: MFine is not fine.
BC startups Kardium, HTEC, Kobalt, Symvivo receive cumulative $11.1 million from feds
The four recipients operate in the life sciences, cleantech, and digital sectors.
Think Research sees 142 percent rise in Q1 revenue fuelled by acquisitions, “major contract wins”
Despite Omicron-related “setbacks,” Think Research sees strong Q1 revenue growth.
Able Innovations announces $7.5 million to take the pain out of patient transfer
Amid staffing shortages, Able aims to enable healthcare workers to “do more with less.”
Doctor-founded Cherry Health closes $1.23 million to expand job-matching platform for physicians
Well Ventures, physician-backed Cherry Health aims to build “digital home for doctors.”
H|T: The Healthtech Times – Zymeworks dodging Dubai bids
Plus: Well Health Technologies posts record Q1 revenue.
Dependbuild, Easy Platter, PragmaClin Research win collective $75,000 from Volta pitch contest
The three startups represent Volta’a 10th cohort for its mentorship program.
H|T: The Healthtech Times – Canadian healthtech stocks struggle to please shareholders
Plus: Peloton’s earnings are even worse than expected.
Well Health Technologies posts record Q1 revenue, announces $30 million bought deal offering to fuel acquisitions
Despite record revenues the last two quarters, Well’s share price has fallen nearly 43 percent over six months.
Dialogue, LifeSpeak struggle to please shareholders with first quarter 2022 results
Both healthtech companies noted user-driven revenue growth while share prices continue to tumble.